Literature DB >> 15373921

Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis.

N Calvani1, H B Richards, M Tucci, G Pannarale, F Silvestris.   

Abstract

There is evidence that nephritis is dominated by a Th1 immune response in systemic lupus erythematosus. Since IL-18 promotes polarization of the immune response toward Th1, we investigated the role of this cytokine in lupus nephritis (LN). A total of 133 lupus patients and 44 healthy subjects were enrolled. Demographic and clinical characteristics with renal biopsy data were recorded. IL-18 along with IFN-gamma and IL-4, two prototypical of Th1 and Th2 cytokines, were measured in serum by ELISA. Peripheral blood lymphocytes were analysed by flow cytometry for IFN-gamma and IL-4. IL-18 expression was determined by immunohistochemistry in 13 renal biopsy specimens from patients with LN and 2 controls. Serum IL-18 was higher in lupus patients than in controls. Levels of IL-18 correlated with urinary microalbumin and were increased in patients with LN when compared to those without LN. IL-18 expression was also increased within the glomeruli of nephritic patients and was primarily detected within the mesangial matrix and in infiltrating mononuclear cells. Measurement of IFN-gamma and IL-4 in either sera or peripheral blood lymphocytes showed high IFN-gamma along with low IL-4 expression in LN patients compared to patients without nephritis. A positive correlation between serum IL-18 and IFN-gamma levels was found. IL-18 may play a prominent role in the pathogenesis of LN by promoting a cytokine imbalance towards a Th1 immune response. Measurement of IL-18 may be helpful for the early identification of lupus patients with LN and may help gauge the response to treatment in patients with active LN undergoing treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15373921      PMCID: PMC1809179          DOI: 10.1111/j.1365-2249.2004.02588.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

Review 1.  Inquiry into murine and human lupus.

Authors:  D M Klinman; A D Steinberg
Journal:  Immunol Rev       Date:  1995-04       Impact factor: 12.988

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes.

Authors:  M H Blotta; R H DeKruyff; D T Umetsu
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

4.  Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis.

Authors:  R Clynes; C Dumitru; J V Ravetch
Journal:  Science       Date:  1998-02-13       Impact factor: 47.728

5.  Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells.

Authors:  T Ohtsuki; M J Micallef; K Kohno; T Tanimoto; M Ikeda; M Kurimoto
Journal:  Anticancer Res       Date:  1997 Sep-Oct       Impact factor: 2.480

6.  Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice.

Authors:  G Fantuzzi; A J Puren; M W Harding; D J Livingston; C A Dinarello
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

7.  Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus.

Authors:  H M Belmont; D Levartovsky; A Goel; A Amin; R Giorno; J Rediske; M L Skovron; S B Abramson
Journal:  Arthritis Rheum       Date:  1997-10

8.  Defective NK cell activity and Th1 response in IL-18-deficient mice.

Authors:  K Takeda; H Tsutsui; T Yoshimoto; O Adachi; N Yoshida; T Kishimoto; H Okamura; K Nakanishi; S Akira
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

9.  Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis.

Authors:  R P Wuthrich
Journal:  Kidney Int       Date:  1992-10       Impact factor: 10.612

10.  Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways.

Authors:  T P Salazar-Mather; J S Orange; C A Biron
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  38 in total

1.  An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage.

Authors:  J Michelle Kahlenberg; Srilakshmi Yalavarthi; Wenpu Zhao; Jeffrey B Hodgin; Tamra J Reed; Noriko M Tsuji; Mariana J Kaplan
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

2.  Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.

Authors:  J Michelle Kahlenberg; Seth G Thacker; Celine C Berthier; Clemens D Cohen; Matthias Kretzler; Mariana J Kaplan
Journal:  J Immunol       Date:  2011-11-04       Impact factor: 5.422

3.  Correlation between serum concentrations of soluble Fas (CD95/Apo-1) and IL-18 in patients with systemic lupus erythematosus.

Authors:  Maryam Sahebari; Zahra Rezaieyazdi; Mohammadreza J Nakhjavani; Mohammadreza Hatef; Mahmoud Mahmoudi; Saaid Akhlaghi
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

4.  Retinal self-antigen induces a predominantly Th1 effector response in Axl and Mertk double-knockout mice.

Authors:  Fei Ye; Lixia Han; Qingjun Lu; Wanwei Dong; Zhenwen Chen; Hui Shao; Henry J Kaplan; Qiutang Li; Qingxian Lu
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

5.  Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.

Authors:  S A Summers; D Odobasic; M B Khouri; O M Steinmetz; Y Yang; S R Holdsworth; A R Kitching
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

6.  IL-18 contributes to renal damage after ischemia-reperfusion.

Authors:  Huiling Wu; Melissa L Craft; Peng Wang; Kate R Wyburn; Gang Chen; Jin Ma; Brett Hambly; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 10.121

Review 7.  The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?

Authors:  J Michelle Kahlenberg; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

Review 8.  Cytokines in systemic lupus erythematosus.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

9.  Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis.

Authors:  Marina Tiumentseva; Vera Morozova; Aleksandr Zakabunin; Denis Korobko; Nadezhda Malkova; Maksim Filipenko; Nina Tikunova
Journal:  Immunogenetics       Date:  2016-01-07       Impact factor: 2.846

10.  Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis.

Authors:  M Tucci; L Lombardi; H B Richards; F Dammacco; F Silvestris
Journal:  Clin Exp Immunol       Date:  2008-09-15       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.